Vnitr Lek 2010, 56(4):324-328

Care for diabetic patients with vascular disease

A. ©mahelová
Diabetologické centrum Kliniky gerontologické a metabolické Lékařské fakulty UK a FN Hradec Králové, přednosta prof. MUDr. Luboą Sobotka, CSc.

There is an association between vascular complications and diabetes compensation in ambulatory as well as inpatient care. Diagnostics of vascular complications in diabetic patients are linked to increased risk of contrast-induced nephropathy. Treatment of severe vascular complications usually requires hospitalization. Achieving and maintaining target glycaemia is essential. Compensation of hyperglycaemia must be sufficient and timely; the risk of hypoglycaemia must not be ignored. Target glycaemia values must be adjusted individually, insulin administration is usually preferred.

Keywords: complications of diabetes; comorbidities of diabetes; contrast-induced nephropathy; target glycaemia; cardiovascular risk; diabetes mellitus

Received: January 3, 2010; Published: April 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©mahelová A. Care for diabetic patients with vascular disease. Vnitr Lek. 2010;56(4):324-328.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. ÚZIS ČR, Aktuální informace č. 36, 2009.
    2. Horák P. Farmakoekonomika léčby diabetu - trendy u nás. Vnitř Lék 2009; 55, 331-342. Go to PubMed...
    3. Almeda-Valdes P, Cuevas-Ramos D, Mehta R et al. UKPDS Risk Engine, Decode and Diabetes PHD Models for the Estimation of Cardiovascular Risk in Patients with Diabetes. Curr Diabetes Rev 2009. Epub ahead of print. Go to original source... Go to PubMed...
    4. Holman RR, Watkins PJ. UKPDS - the first 30 years. Oxford: Wiley-Blackwell 2008.
    5. Kauffman AB, Delate T, Olson KL et al. Relationship between haemoglobin A1C values and recurrent cardiac events: A retrospective, longitudinal cohort study. Clin Drug Investig 2008; 28: 501-507. Go to original source... Go to PubMed...
    6. Schwab SJ, Hlatky MA, Pieper KS et al. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 1989; 320: 149-153. Go to original source...
    7. Asif A, Epstein M. Prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 2004; 44: 12-24. Go to original source... Go to PubMed...
    8. Schweiger MJ, Chambers CE, Davidson CJ et al. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv 2007; 69: 135-140. Go to original source... Go to PubMed...
    9. Rudnick M, Feldman H. Contrast-induced nephropathy: what are the true clinical consequences? Clin J Am Soc Nephrol 2008; 3: 263-272. Go to original source... Go to PubMed...
    10. Gruberg L, Mintz GS, Mehran R et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000; 36: 1542-1548. Go to original source... Go to PubMed...
    11. Rihal CS, Textor SC, Grill DE et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259-2264. Go to original source... Go to PubMed...
    12. Dussol B, Morange S, Loundoun A et al. A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients. Nephrol Dial Transplant 2006; 21: 2120-2126. Go to original source... Go to PubMed...
    13. Calabrese AT, Coley KC, DaPos SV et al. Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy. Arch Intern Med 2002; 162: 434-437. Go to original source... Go to PubMed...
    14. Holstein A, Stumvoll M. Contraindications can damage your health - is metformin a case in point? Diabetologia 2005; 48: 2454-2459. Go to original source... Go to PubMed...
    15. Briguori C, Airoldi F, D'Andrea D et al. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 2007; 115: 1211-1217. Go to original source... Go to PubMed...
    16. ©mahelová A. Konzervativní léčba diabetické mikroangiopatie a makroangiopatie. Čas Lék Čes 2009; 148: 72-79.
    17. NovoNordisk Book if Abstracts, Internatiional Diabetes Federation 20th World Diabetes Congress, Montreal, 18.-2 2. October 2009.
    18. ZS/1a/10 Postupy pro diagnostiku a terapii vybraných stavů závazné pro zdravotnická pracoviątě FN HK A ZS/4-PPZ/10.
    19. Finfer S, Chittock DR, Su SY et al. NICE SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-1297. Go to original source... Go to PubMed...
    20. Clement S, Braithwaite SS, Magee MF et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004; 27: 553-591. Go to original source... Go to PubMed...
    21. Fonseca VA. Clinical Diabetes: translating Research into Practice. 1st ed. Philadelphia: Saunders Elsevier 2006.
    22. Malmberg K, Norhammar A, Wedel H et al. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999; 99: 2626-2632. Go to original source... Go to PubMed...
    23. van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-1867. Go to original source... Go to PubMed...
    24. Malmberg K, Rydén L, Wedel H et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity Eur Heart J 2004; 26: 650-661. Go to original source... Go to PubMed...
    25. van den Berghe G. Insulin vs. strict blood glucose control to achieve a survival benefit after AMI? Eur Heart J 2005; 26: 639-641. Go to original source... Go to PubMed...
    26. Hirsch IB. Were We Wrong About Insulin and Acute Myocardial Infarction? DOC News. 2004. Available from: http://docnews.diabetesjournals.org/content/1/2/4.full.
    27. Wei M, Gibbons LW, Mitchell TL et al. Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality. Circulation 2000; 101: 2047-2052. Go to original source... Go to PubMed...
    28. Whitmer RA, Gunderson EP. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. JAMA 2009; 301: 1565-1572. Go to PubMed...
    29. Gill GV, Woodward A, Casson IF et al. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes - the "dead in bed" syndrome revisited. Diabetologia 2009; 52: 42-45. Go to original source... Go to PubMed...
    30. Tu E, Twigg SM, Semsarian C. Sudden death in type 1 diabetes: the mystery of the 'dead in bed' syndrome. Int J Cardiol 2010; 138: 91-93. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.